RCKT

NASDAQ · Biotechnology

Rocket Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.56

+0.08 (+2.30%)

As of May 9, 1:53 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 11 55%

Hold 7 35%

Sell 2 10%

Price Target

Analyst Price Target +373.9% upside

Low Target $13.87

Average Target $16.87

High Target $23.44

Current Price $3.56

Current
$3.56

Target
$16.87

$13.87 $16.87 avg $23.44

Scenario Analysis

Bear Case

$13.87

289.6%

Low target

Base Case

$16.87

+373.9%

Avg target

Bull Case

$23.44

+558.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$7.39

-51.8% from high

52-Week Low

$2.19

+62.6% from low

Target vs 52W High

$16.87

+128.3% vs high

Next Earnings Report

May 11, 2026 · After Market Close

Today

EPS Est: $-0.42

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%